Associated Papers
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.
Muñoz-Mármol AM et al.
Cancers, 2025
39941744 (PubMed )
Supplement: cancers-17-00375-s001.zip › cancers-3382881-Supplementary_Table_S3.xlsx › Hoja1
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
Jung H et al.
Nature Communications, 2019
31537801 (PubMed )
Supplement: 41467_2019_12159_MOESM8_ESM.xlsx › Sheet1
Select a paper to view details